Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
A piece by Becker's Payer Issues cited an article published on AJMC.com, the website of The American Journal of Managed Care® (AJMC®). The article, “Payers Need Enhanced Utilization Management to Optimize High-Cost Therapies, Panel Says,” covered a session at the Academy of Managed Care Pharmacy (AMCP) Nexus 2022 discussing enhanced utilization management strategies to manage the rising cost of specialty drugs.
A piece by Health Digest referenced an article published on AJMC.com titled “Understanding the Relationship Between Dry Eye and Migraine.” The article covered findings of a review indicating that dry eye and migraine may have a shared pathophysiology, with therapies targeting similar pathophysiological mechanisms.
Taletrectinib Recommended in NCCN Guidelines for ROS1-Positive NSCLC
July 31st 2025Taletrectinib was added to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology as a preferred option for the first-line and subsequent treatment of advanced ROS1-positive non–small cell lung cancer (NSCLC).
Read More
Managed Care Reflections: A Q&A With Charles N. (Chip) Kahn III, MPH
July 30th 2025To mark the 30th anniversary of The American Journal of Managed Care (AJMC), each issue in 2025 includes a special feature: reflections from a thought leader on what has changed—and what has not—over the past 3 decades and what’s next for managed care. The August issue features a conversation with Charles N. (Chip) Kahn III, MPH, the president and CEO of the Federation of American Hospitals and a longtime member of the AJMC editorial board.
Read More
As CMS Embarks on “Rural Transformation,” a New Jersey Health System Weighs In
July 19th 2025CMS Administrator Mehmet Oz, MD, MBA, visited AtlantiCare leaders in Atlantic City, New Jersey, to discuss the need for legislative and regulatory reform, as well as the $50 billion Rural Transformation Program.
Read More